Through CancerLinQ Discovery®, we provide access to de-identified real-world data sets to researchers from CancerLinQ practices, academia, government, cancer research centers, medical societies and other nonprofit organizations that can generate practical knowledge to shape the future of cancer care. The data sets include curated sets of aggregated, de-identified data on a variety of cancer types that can be studied to improve patient care delivery.
Available Data Sets
CancerLinQ is proud to offer CancerLinQ Discovery data sets across the following 10 tumor types.
A Community That Learns Together
CancerLinQ Discovery is building a community that learns together and shares insights to improve patient care and outcomes. In 2016, Founding Enterprise Partner AstraZeneca became the first industry strategic partner to join in the mission of CancerLinQ Discovery. Since then, CancerLinQ has established collaborations with government agencies, including the U.S. Food and Drug Administration, medical specialty societies, and other health technology companies. Interested in joining their collaborative community of learning? Email firstname.lastname@example.org.